Bayer backs broadened effort to shield popular weedkiller from claims it failed to warn of cancer
The global chemical maker Bayer is backing an expanded effort to shield itself from lawsuits alleging its popular weedkiller ...
Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma
Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCCAmezalpat builds momentum with both ...